BioLife Solutions (BLFS) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.08
- Estimate
- $0.06
- Surprise
- +40.5%
- Revenue (period 2026-06-30)
- $28.5M
- Score today
- 5.2/10
Revenue source: xbrl.
How the report landed
BioLife Solutions (BLFS) beat the $0.06 estimate with diluted EPS of $0.08 — a large 40.5% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates BLFS Sell at 5.2/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's +40.5% surprise compares with a +719.7% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- Strong earnings beat streak (3/4)
- Strong growth profile
What argues against it
- Concentration risk — Product: CryoStor products (82.0%)
- Concentration risk — Geographic: United States (80.0%)
- Earnings expected to decline ~67% (cyclical peak)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $37.10
- Price target
- $42.66
- Stop
- $34.96
- Upside to target
- +15.0%
Forward estimates sit below the trailing run-rate (112.4× forward vs 37.1× trailing) — consensus expects earnings to decline from here.
Risk check: RSI 89 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-08-23 — shown for context, not personalized investment advice.
BLFS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $1.81B
- P/E (fwd)
- 112.4
- P/E (ttm)
- 37.1
- 52-week range
- $17.86–$38.10
- Off 52-week high
- 2.6%
- RSI (14)
- 89
- Volume vs avg
- 1.06×
- Score today
- 5.2/10